Yahoo Finance

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
Business Wire

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
WFMZ-TV

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...
NPR

War can't entirely eliminate Iran's nuclear program, the U.N. atomic energy chief says

The United Nations' nuclear watchdog chief says he does not believe the war in Iran can entirely eliminate the nation's nuclear program, even if the main facilities are heavily damaged. And Iran ...
Mint

Homeland Security nominee Markwayne Mullin to outline immigration strategy amid deportation push at Senate hearing today

Senator Markwayne Mullin, President Donald Trump's pick for Secretary of Homeland Security, will appear before the Senate on Wednesday (March 18) for his confirmation hearing, where he will face ...